Skip to main content
Log in

UFT for head and neck cancers: its tissue concentrations and effects on lymphocyte subpopulations

  • Original Articles
  • UFT, Head and Neck Cancer
  • Published:
Cancer Chemotherapy and Pharmacology Aims and scope Submit manuscript

Summary

UFT, a combination of the masked compound of 5-fluorouracil (FT-207) and uracil, was given to head and neck cancer patients for 1 week preoperatively and for 8 weeks postoperatively. Drug concentrations were examined in the surgically removed tissues. The concentrations of FT-207, 5-fluorouracil, and uracil were higher in tumor tissues than in normal tissues. The lymphocyte subpopulations were assessed by cytofluorometry with monoclonal antibodies. There was no evidence that adjuvant chemotherapy with UFT specifically suppresses immunocompetent cells. We therefore conclude that further clinical evaluation of adjuvant chemotherapy with UFT would be worthwhile.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Fujii S, Ikenaka K, Fukushima M, Shirasaka T (1978) Effect of uracil and its derivatives on antitumor activity of 5-fluorouracil and 1-(2-tetrahydrofuryl)-5-fluorouracil. Cann 69:763

    Google Scholar 

  2. Fujii S, Kitano S, Ikenaga K, Shirasaka T (1979) Studies on coadministration of uracil or cytosine on antitumor activity of FT-207 or 5-FU derivatives. Jpn J Cancer Chemother 6:377

    Google Scholar 

  3. Inuyama Y, Fujii M, Mashino S, Tanaka J, Takaoka T, Kohno N (1983) Clinical effect of UFT therapy for head and neck cancer. Jpn J Cancer Chemother 10: 90

    Google Scholar 

  4. Kimura K, Isobe Y, Suga S, Suzuoki Y, Kondo C, Shimoyama M, Sakano T, Inoue K (1979) Enhancement of anticancer effects by change of drug formulation, with special reference to Oil Bleomycin, intrarectal use of FT-207, and combination of uracil and FT-207. Jpn J Cancer Chemother 6:237

    Google Scholar 

  5. Marunaka T, Umeno Y, Yoshida K, Nagamachi M, Minami Y, Fujii S (1980) High-pressure liquid chromatographic determination of Ftoraful [1-(tetrahydro-2-furanyl)-5-fluorouracil] and GLC-mass spectrometric determination of 5-fluorouracil and uracil in biological materials after oral administration of uracil plus Ftoraful. J Pharm Sci 11:1296

    Google Scholar 

  6. Nakashima T, Matsumura Y, Nomura Y, Komiyama S, Makishima K, Hiroto I (1982) Antitumor effect of UFT against malignant tumors of maxillary sinus — Clinical and biochemical study. Jpn J Cancer Chemother 9:1729

    Google Scholar 

  7. Taguchi T, Nakano Y, Jikuya K, Fujii S, Ikenaka K, Fukushima M, Shirasaka T (1978a) Effect of uracil on the antitumor activity of Futraful. Jpn J Cancer Chemother 5:1161

    Google Scholar 

  8. Taguchi T, Nakano Y, Fujii S, Shirasaka T (1978b) Determination of 5-fluorouracil levels in tumors, blood, and other tissues. Jpn J Cancer Chemother 5:1167

    Google Scholar 

  9. Yamada Y, Toko T, Miyauchi S, Unemi N (1980) Effect of UFT on immune responses in mice. Cancer Chemother 7: 2134

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tachibana, M., Yasuda, N., Yoshimatsu, M. et al. UFT for head and neck cancers: its tissue concentrations and effects on lymphocyte subpopulations. Cancer Chemother. Pharmacol. 19, 65–68 (1987). https://doi.org/10.1007/BF00296259

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00296259

Keywords

Navigation